Surgical choroidal neovascular membrane removal in the era of anti-vascular endothelial growth factor agents.
Indian J Ophthalmol
;
2009 Mar-Apr; 57(2): 146-8
Artículo
en Inglés
| IMSEAR
| ID: sea-69920
ABSTRACT
Intravitreal anti-vascular endothelial growth factor (VEGF) agents have obtained acceptance as the mainstay in the management strategy of subfoveal choroidal neovascular membranes (CNVM) due to varying etiologies. Few drawbacks include need for repeated intravitreal injections, with its adjunct risks, and the lack of a predefined treatment end point, which can cause doubts and uncertainty in the mind of the patient. Furthermore, it remains a significant financial burden for the patient. Herein we report our data of three patients who were reluctant for further re-injections of anti-VEGF agents and were therefore offered surgical removal of the CNVM by submacular surgery as an alternative treatment plan.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Procedimientos Quirúrgicos Oftalmológicos
/
Humanos
/
Masculino
/
Agudeza Visual
/
Adulto
/
Neovascularización Coroidal
/
Inhibidores de la Angiogénesis
/
Factor A de Crecimiento Endotelial Vascular
/
Tomografía de Coherencia Óptica
/
Membranas
Idioma:
Inglés
Revista:
Indian J Ophthalmol
Año:
2009
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS